Statin induced regression of cardiomyopathy trial: A randomized, placebo-controlled double-blind trial

Statin induced regression of cardiomyopathy trial: A randomized, placebo-controlled double-blind trial

Background: Hypertrophic cardiomyopathy (HCM), characterized by a thickened, fibrotic myocardium, remains the most common cause of sudden cardiac death in young adults. Based on animal and clinical data, we hypothesized that atorvastatin would induce left ventricular (LV) mass regression. Methods: S...

Full description

Bibliographic Details
Main Authors: Ahmad Hersi, J Peter Giannoccaro, Andrew Howarth, Derek Exner, Sarah Weeks, Ingo Eitel, R Cameron Herman, Henry Duff, Debbie Ritchie, Maureen Mcrae, Robert Sheldon
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:Heart Views
Subjects:
Atorvastatin
clinical trial
hypertrophic cardiomyopathy
regression
statin
Online Access:http://www.heartviews.org/article.asp?issn=1995-705X;year=2016;volume=17;issue=4;spage=129;epage=135;aulast=Hersi

Internet

http://www.heartviews.org/article.asp?issn=1995-705X;year=2016;volume=17;issue=4;spage=129;epage=135;aulast=Hersi

Similar Items